PKIS v2.0 A clinical tool for identifying important pharmacokinetic drug-drug interactions
| 1. Accepted major perpetrators | 2. Rejected perpetrators | 3. Unclassifiable | 4. Full table |

clinafloxacin

  • clinafloxacin is not available in Australia/New Zealand, despite evidence suggesting that it may perturb the activities of CYP1A2.
  • CYP1A2
    Not available in Australia or New Zealandarmodafinil
    artemisinin
    clinafloxacin
    enoxacin
    etintidine
    furafylline
    idrocilamide
    methylcholanthrene
    mibefradil
    nafcillin
    oltipraz
    perfloxacin
    phenylpropanolamine
    pipemidic acid
    rofecoxib
    stiripentol
    thiabendazole
    troleandomycin
    zileuton

    Footnotes and References

    Disclaimer
    WARNING: While all efforts were put in to maintain the accuracy and currency of the information, it is possible that the knowledge and electronic tools may contain errors and inadequacy. Both Flinder's University and University of New South Wales are not liable to any damages or losses resulted from such circumstances. Clinical discretions are strongly advised at all times.